Sahar Israeli Dangoor

Mrs. Sahar Israeli Dangoor

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
EYEilam Yeini
Eilam Yeini
POPaula Ofek
Paula Ofek
Sabina PozziSabina Pozzi
Sabina Pozzi
NANitzan Albeck
Nitzan Albeck
DBDikla Ben-Shushan
Dikla Ben-Shushan
RSRonit Satchi-Fainaro
Ronit Satchi-Fainaro
Glioblastoma (GB) is a highly invasive type of brain cancer exhibiting poor prognosis. As such, its microenvironment plays a crucial role in its progression. Among the brain stromal cells, the microglia were shown to facilitate GB invasion and immunosuppression. However, the reciprocal mechanisms by which GB cells alter microglia/macrophages behavior are not fully understood. We propose that these mechanisms involve adhesion molecules such as the Selectins family. These proteins are involved in immune modulation and cancer immunity. We show that P-selectin mediates microglia-enhanced GB proliferation and invasion by altering microglia/macrophages activation state. We demonstrate these findings by pharmacological and molecular inhibition of P-selectin which leads to reduced tumor growth and increased survival in GB mouse models. Our work sheds light on tumor-associated microglia/macrophage function and the mechanisms by which GB cells suppress the immune system and invade the brain, paving the way to exploit P-selectin as a target for GB therapy.

1 August 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Sabina PozziSabina Pozzi
Sabina Pozzi
ASAnna Scomparin
Anna Scomparin
SDSahar Israeli Dangoor
Sahar Israeli Dangoor
DADaniel Rodriguez Ajamil
Daniel Rodriguez Ajamil
POPaula Ofek
Paula Ofek
RSRonit Satchi-Fainaro
Ronit Satchi-Fainaro

24 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAdiki Raja Sekhar
Adiki Raja Sekhar
YCYouhei Chitose
Youhei Chitose
JJJiří Janoš
Jiří Janoš
SDSahar Israeli Dangoor
Sahar Israeli Dangoor
ARAndrea Ramundo
Andrea Ramundo
RWRoy Weinstain
Roy Weinstain
Photoremovable protecting groups (PPGs) represent one of the main contemporary implementations of photochemistry in diverse fields of research and practical applications. For the past half century, organic and metal-complex PPGs were considered mutually exclusive classes, each of which provided unique sets of physical and chemical properties thanks to their distinctive structures. Here, we introduce the meso-methylporphyrin group as a prototype hybrid-class PPG that unites traditionally exclusive elements of organic and metal-complex PPGs within a single structure. We show that the porphyrin scaffold allows extensive modularity by functional separation of the metal-binding chromophore and up to four sites of leaving group release. The insertion of metal ions can be used to tune their spectroscopic, photochemical, and biological properties. We provide a detailed description of the photoreaction mechanism studied by steady-state and transient absorption spectroscopies and quantum-chemical calculations. Our approach applied herein could facilitate access to a hitherto untapped chemical space of potential PPG scaffolds.

25 October 2024 in Brain
Verified
Journal Article
Open access
PDF file
SDSahar Israeli Dangoor
Sahar Israeli Dangoor
RKRami Khoury
Rami Khoury
KSKoren Salomon
Koren Salomon
SPSabina Pozzi
Sabina Pozzi
SSShir Shahar
Shir Shahar
RSRonit Satchi-Fainaro
Ronit Satchi-Fainaro
Over the last two decades, the diagnosis and treatment of breast cancer patients have considerably improved. However, brain metastases remain a major clinical challenge and a leading cause of mortality. Thus, a better understanding of the pathways involved in the metastatic cascade is essential. To this end, we have investigated the reciprocal effects of astrocytes and breast cancer cells, employing traditional 2-dimensional cell culture and our unique 3-dimensional multicellular tumoroid models. Our findings revealed that astrocytes enhance the proliferation, migration, and invasion of breast cancer cells, suggesting a supportive role for astrocytes in breast cancer outgrowth to the brain. Elucidating the key players in astrocyte-breast cancer cells crosstalk, we found that CCL2 is highly expressed in breast cancer brain metastases tissue sections from both patients and mice. Our in vitro and in vivo models further confirmed that CCL2 has a functional role in brain metastasis. Given their aggressive nature, we sought additional immune checkpoints for rationale combination therapy. Among the promising candidates were the adhesion molecule P-selectin, which we have recently shown to play a key role in the crosstalk with microglia cells, and the co-inhibitory receptor PD-1, the main target of currently approved immunotherapies. Finally, combining CCL2 inhibition with immunomodulators targeting either PD-1/PD-L1 or P-selectin/P-Selectin Ligand-1 axes in our human 3-dimensional tumoroid models and in vivo presented more favorable outcomes than each monotherapy. Taken together, we propose that CCL2-CCR2/CCR4 is a key pathway promoting breast cancer brain metastases and a promising target for an immunotherapeutic combination approach.

29 December 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KLKathrin Laue
Kathrin Laue
SPSabina Pozzi
Sabina Pozzi
JZJohanna Zerbib
Johanna Zerbib
RBRebecca Bertolio
Rebecca Bertolio
YEYonatan Eliezer
Yonatan Eliezer
UBUri Ben-David
Uri Ben-David

20 December 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AKAdva Krivitsky
Adva Krivitsky
SPSabina Pozzi
Sabina Pozzi
EYEilam Yeini
Eilam Yeini
SDSahar Israeli Dangoor
Sahar Israeli Dangoor
TZTal Zur
Tal Zur
RSRonit Satchi-Fainaro
Ronit Satchi-Fainaro
Development of chemo-resistance is a major challenge in glioblastoma (GB) treatment. This phenomenon is often driven by increased activation of genes associated with DNA repair, such as the alkyl-removing enzyme O6-methylguanine-DNA methyltransferase (MGMT) in combination with overexpression of canonical genes related to cell proliferation and tumor progression, such as Polo-like kinase 1 (Plk1). Hereby, we attempt to sensitize resistant GB cells using our established amphiphilic poly(α)glutamate (APA): small interfering RNA (siRNA) polyplexes, targeting Plk1. Furthermore, we improved brain-targeting by decorating our nanocarrier with sulfonate groups. Our sulfonated nanocarrier showed superior selectivity towards P-selectin (SELP), a transmembrane glycoprotein overexpressed in GB and angiogenic brain endothelial cells. Self-assembled polyplexes of sulfonated APA and siPlk1 internalized into GB cells and into our unique 3-dimensional (3D) GB spheroids inducing specific gene silencing. Moreover, our RNAi nanotherapy efficiently reduced the cell viability of both chemo-sensitive and chemo-resistant GB cells. Our developed sulfonated amphiphilic poly(α)glutamate nanocarrier has the potential to target siRNA to GB brain tumors. Our findings may strengthen the therapeutic applications of siRNA for chemo-resistant GB tumors, or as a combination therapy for chemo-sensitive GB tumors.